CAN
NTLA icon

Cetera Advisor Networks’s Intellia Therapeutics NTLA Stock Holding History

Cetera Advisor Networks’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.14M Buy
41,427
+32,862
+384% +$913K 0.01% 1365
2023
Q4 		$261K Buy
8,565
+701
+9% +$20.1K ﹤0.01% 2335
2023
Q3 		$249K Sell
7,864
-4,758
-38% -$185K ﹤0.01% 2272
2023
Q2 		$515K Buy
12,622
+4,216
+50% +$171K ﹤0.01% 1693
2023
Q1 		$313K Buy
+8,406
New +$330K ﹤0.01% 2029

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cetera Advisor Networks's NTLA Position: Q1 2024 in Review

Cetera Advisor Networks increased its Intellia Therapeutics (NTLA) stake by 384% in Q1 2024, buying an estimated $913K and bringing the position to 41,427 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #1365.

Cetera Advisor Networks first reported a position in NTLA in Q1 2023 and has held it in 5 quarters since. 285 funds tracked by Wall St. Rank hold NTLA as of Q1 2024.

  • Cetera Advisor Networks held 41,427 shares of Intellia Therapeutics worth $1.14M as of Q1 2024.
  • Cetera Advisor Networks bought 32,862 Intellia Therapeutics shares in Q1 2024, an estimated $913K.
  • Intellia Therapeutics made up 0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1365 holding.
  • Cetera Advisor Networks first reported a position in Intellia Therapeutics in Q1 2023 and has held it in 5 quarters since.
  • 285 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.